reference/32520008

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32520008

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	8303
issn	1178-2013
pageRange	8279-8303
publicationName	International Journal of Nanomedicine
startingPage	8279
bibliographicCitation	Sun Y, Xie Y, Tang H, Ren Z, Luan X, Zhang Y, Zhu M, Lv Z, Bao H, Li Y, Liu R, Shen Y, Zheng Y, Pei J. In vitro and in vivo Evaluation of a Novel Estrogen-Targeted PEGylated Oxaliplatin Liposome for Gastric Cancer. Int J Nanomedicine. 2021;16():8279–303. PMID: 34992365; PMCID: PMC8712509.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ff71ac22027f73a7d7edc3b52c484c29 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_29a990664bc62a5d7406718e62419e49 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3078576da148735fb0a264cdb356562 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e6348d24cd07f20a4b712cbe039c55cb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f4e250a0f2154fc5cd752e6cfe40b84 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b934c67b58a800b8d5a76f26acec651 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b39088e7734dbbabedba7b98eb0bd21 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5c1b732118fa0f01390312fc318af2e1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6213-6267 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_09b69bbcfcb99aa27296aa509be977ca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9416a6b5ea42f1d44b52ccf254dafe57 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0b954baf86ee02fa23a94a70f1f89470 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_704788201059cd65041addd2d7e8786c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e8b18f3307c3cd0cbec25550d70d6f48
date	202112
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC8712509 https://doi.org/10.2147/ijn.s340180 https://pubmed.ncbi.nlm.nih.gov/34992365
isPartOf	https://portal.issn.org/resource/ISSN/1178-2013 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32688
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	In vitro and in vivo Evaluation of a Novel Estrogen-Targeted PEGylated Oxaliplatin Liposome for Gastric Cancer
discusses	http://id.nlm.nih.gov/mesh/M0007795 http://id.nlm.nih.gov/mesh/M0095550 http://id.nlm.nih.gov/mesh/M0017182 http://id.nlm.nih.gov/mesh/M0012600
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D013274Q000188 http://id.nlm.nih.gov/mesh/D008081
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D011092 http://id.nlm.nih.gov/mesh/D000077150 http://id.nlm.nih.gov/mesh/D004967 http://id.nlm.nih.gov/mesh/D008813 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D014018 http://id.nlm.nih.gov/mesh/D045744
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9415 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9305 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b86932d00e38733ad1047458f3dfe3ed http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9887053 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449

Showing number of triples: 1 to 52 of 52.